973 related articles for article (PubMed ID: 23292117)
1. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells.
Li G; He L; Zhang E; Shi J; Zhang Q; Le AD; Zhou K; Tang X
Cancer Lett; 2011 Dec; 311(2):160-70. PubMed ID: 21868151
[TBL] [Abstract][Full Text] [Related]
3. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
4. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.
Zhang E; Feng X; Liu F; Zhang P; Liang J; Tang X
PLoS One; 2014; 9(7):e103440. PubMed ID: 25058399
[TBL] [Abstract][Full Text] [Related]
5. ERK Signaling Pathway Is Involved in HPV-16 E6 but not E7 Oncoprotein-Induced HIF-1α Protein Accumulation in NSCLC Cells.
Liu F; Lin B; Liu X; Zhang W; Zhang E; Hu L; Ma Y; Li X; Tang X
Oncol Res; 2016; 23(3):109-18. PubMed ID: 26931433
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.
Li X; Feng Y; Liu J; Feng X; Zhou K; Tang X
J Nutrigenet Nutrigenomics; 2013; 6(3):169-78. PubMed ID: 24008975
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.
Liu LZ; Fang J; Zhou Q; Hu X; Shi X; Jiang BH
Mol Pharmacol; 2005 Sep; 68(3):635-43. PubMed ID: 15947208
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
[TBL] [Abstract][Full Text] [Related]
9. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
11. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
12. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
[TBL] [Abstract][Full Text] [Related]
14. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
17. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
18. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
[TBL] [Abstract][Full Text] [Related]
20. EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells.
Luo HQ; Xu M; Zhong WT; Cui ZY; Liu FM; Zhou KY; Li XY
J BUON; 2014; 19(2):435-9. PubMed ID: 24965403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
